Regulation of Inflammatory and Metabolic Microenvironment With a D‐Mannose Functionalized Hydrogel for Improved Osteochondral Regeneration
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Wenhui Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Hydrogels, Mannose, Inflammation, Bone Regeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Nanjing Medical Science and Technology Development Foundation, Science and Technology Development Fund of Nanjing Medical University.
Abstract (Originalsprache)
Endogenous regenerative strategy for osteochondral defect (OCD) repair remains challenging, largely due to the need to regulate the local inflammatory and metabolic microenvironment while preserving the stemness of bone marrow mesenchymal stem cells (BMSCs). Here, D‐mannose we identify as a potent immunometabolic modulator that enhances BMSC‐mediated osteochondral repair. Through in vitro experiments, we determined the optimal concentration of D‐mannose and evaluated its ability to preserve the osteogenic and chondrogenic differentiation potential of BMSCs under inflammatory microenvironment. Transcriptomic analysis demonstrated that D‐mannose contributed to the amelioration of inflammation by downregulating the NLRP3 inflammasome pathway. The metabolomic analysis further revealed that D‐mannose treatment alleviated inflammation‐induced dysregulation of the tricarboxylic acid cycle and facilitated the maintenance of glycolytic metabolic state in BMSCs. Furthermore, we fabricated a multifunctional GelMA‐based hydrogel incorporating D‐mannose (DM@GelMA). Macroscopic observation, micro‐CT analysis and histological evaluation confirmed that DM@GelMA hydrogel effectively promoted osteochondral tissue remodeling and integration in the OCD model of rats. These findings suggested that the multifunctional D‐mannose‐loaded composite hydrogel is a promising biomaterial for enhanced osteochondral regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
- Key Lab of Additive Manufacturing Technology, Institute of Digital Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
- Cartilage Regeneration Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
ORCID-Profile: Changyan Ma, Cheng Tang
Förderung
- National Key Research and Development Program of China
- Nanjing Medical Science and Technology Development Foundation
- Science and Technology Development Fund of Nanjing Medical University
Zitieren
APA
Hu, W., Cao, Z., Wang, M., Dong, Z., Wang, Y., Zhang, X., Xu, Y., Wang, L., Ma, C., & Tang, C. (2026). Regulation of Inflammatory and Metabolic Microenvironment With a D‐Mannose Functionalized Hydrogel for Improved Osteochondral Regeneration. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503687
Vancouver
Hu W, Cao Z, Wang M, Dong Z, Wang Y, Zhang X, et al. Regulation of Inflammatory and Metabolic Microenvironment With a D‐Mannose Functionalized Hydrogel for Improved Osteochondral Regeneration. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503687
BibTeX
@article{Hu2026,
author = {Hu, Wenhui and Cao, Zhicheng and Wang, Mengtao and Dong, Zhiwen and Wang, Yufeng and Zhang, Xin and Xu, Yan and Wang, Liming and Ma, Changyan and Tang, Cheng},
title = {Regulation of Inflammatory and Metabolic Microenvironment With a D‐Mannose Functionalized Hydrogel for Improved Osteochondral Regeneration},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503687}
}
EUVIMED